Mechanisms and measures to modulate T cell trafficking for amplified and tolerogenic immunity
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Immunotherapy and Immune Responses · CAR-T cell therapy research · T-cell and B-cell Immunology
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Local production of the chemokines CCL5 and CXCL10 attracts CD8 + T lymphocytes into esophageal squamous cell carcinoma10.18632/oncotarget.4617 ↗
2. Neutrophil trails guide influenza-specific CD8+ T cells in the airways10.1126/science.aaa4352 ↗
3. Unique chemotactic response profile and specific expression of chemokine receptors Ccr4 and Ccr8 by Cd4+Cd25+ regulatory T cells10.1084/jem.194.6.847 ↗
4. Dendritic cell subsets in T cell programming: location dictates function10.1038/s41577-018-0088-1 ↗
5. Targeting lymph node niches enhances type 1 immune responses to immunization10.1016/j.celrep.2020.107679 ↗
6. CXCR3 chemokine receptor-ligand interactions in the lymph node optimize CD4+ T helper 1 cell differentiation10.1016/j.immuni.2012.08.016 ↗
7. Functional reprogramming of human prostate cancer to promote local attraction of effector CD8+ T cells10.1002/pros.23194 ↗
8. Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment10.1158/0008-5472.CAN-08-2281 ↗
9. Cooperation between constitutive and inducible chemokines enables T cell engraftment and immune attack in solid tumors10.1016/j.ccell.2019.05.004 ↗
10. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts10.1038/ni1333 ↗
11. PRC2 epigenetically silences Th1-type chemokines to suppress effector T-cell trafficking in colon cancer10.1158/0008-5472.CAN-15-1938 ↗
12. Exosomes released from tumor-associated macrophages transfer miRNAs That Induce a Treg/Th17 cell imbalance in epithelial ovarian cancer10.1158/2326-6066.CIR-17-0479 ↗
13. CXCL10-producing mucosal CD4+ T cells, NK Cells, and NKT cells are associated with chronic colitis in IL-10−/− mice, which can be abrogated by Anti-CXCL10 antibody inhibition10.1089/jir.2007.0059 ↗
14. Cerebrospinal fluid interferon-γ-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection10.1016/j.jneuroim.2005.07.002 ↗
15. Orchestrating the orchestrators: chemokines in control of T cell traffic10.1038/ni.f.213 ↗
16. Neuronal CXCL10 Directs CD8+ T-cell recruitment and control of West Nile virus encephalitis10.1128/JVI.79.17.11457-11466.2005 ↗
17. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria10.1073/pnas.0801544105 ↗
18. Splenic differentiation and emergence of CCR5+CXCL9+CXCL10+ monocyte-derived dendritic cells in the brain during cerebral malaria10.1038/ncomms13277 ↗
19. CXCL9 and CXCL10 bring the heat to tumors10.1126/sciimmunol.abq6509 ↗
20. Pro-inflammatory β cell small extracellular vesicles induce β cell failure through activation of the CXCL10/CXCR3 axis in diabetes10.1016/j.celrep.2021.109613 ↗
21. CXCR3 chemokine receptor enables Local CD8+ T cell migration for the destruction of virus-infected cells10.1016/j.immuni.2015.02.009 ↗
22. Requirement of the chemokine receptor CXCR3 for acute allograft rejection10.1084/jem.192.10.1515 ↗
23. Inflammatory triggers of acute rejection of organ allografts10.1111/imr.12146 ↗
24. CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment10.1016/j.cell.2021.07.015 ↗
25. Functional specialization of gut CD103(+) dendritic cells in the regulation of tissue-selective T cell homing10.1084/jem.20051100 ↗
26. Hypermethylation at the CXCR5 gene locus limits trafficking potential of CD8+ T cells into B-cell follicles during HIV-1 infection10.1182/bloodadvances.2021006001 ↗
27. Cytokine-induced killer cells interact with tumor lysate–pulsed dendritic cells via CCR5 signaling10.1016/j.canlet.2016.05.020 ↗
28. CCL5 release by CCR9+ CD8 T cells: a potential contributor to immunopathology of primary Sjögren’s syndrome10.3389/fimmu.2022.887972 ↗
29. T regulatory cell chemokine production mediates pathogenic T cell attraction and suppression10.1172/JCI83987 ↗
30. Chemokine receptor CXCR3 facilitates CD8(+) T cell differentiation into short-lived effector cells leading to memory degeneration10.1084/jem.20102101 ↗
31. Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell–dendritic cell interaction10.1038/nature04651 ↗
32. The chemokine receptor CCR5 plays a key role in the early memory CD8+ T cell response to respiratory virus infections10.1016/j.immuni.2008.05.011 ↗
33. The role of CC chemokine receptor 5 (CCR5) in islet allograft rejection10.2337/diabetes.51.8.2489 ↗
34. CCL5 mediates CD40-driven CD4+ T cell tumor infiltration and immunity10.1172/jci.insight.137263 ↗
35. TH1 and TH17 cells promote crescent formation in experimental autoimmune glomerulonephritis10.1002/path.4559 ↗
36. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis10.4049/jimmunol.0802626 ↗
37. High expression of the CC chemokine TARC in reed-sternberg cells: a possible explanation for the characteristic T-cell infiltrate in Hodgkin's lymphoma10.1016/S0002-9440(10)65424-7 ↗
38. Differential expression of chemokines and chemokine receptors in murine islet allografts: the role of CCR2 and CCR5 signaling pathways10.1097/01.ASN.0000130622.48066.D9 ↗
39. A subset of Interleukin-21+ chemokine receptor CCR9+ T helper cells target accessory organs of the digestive system in autoimmunity10.1016/j.immuni.2011.01.021 ↗
40. T follicular helper cell differentiation, function, and roles in disease10.1016/j.immuni.2014.10.004 ↗
41. Chemokine guidance of central memory T cells is critical for antiviral recall responses in lymph nodes10.1016/j.cell.2012.08.015 ↗
42. The bone marrow protects and optimizes immunological memory during dietary restriction10.1016/j.cell.2019.07.049 ↗
43. , IL-1β-activated mTORC2 promotes accumulation of IFN-γ+ γδ T cells by upregulating CXCR3 to restrict hepatic fibrosis10.1038/s41419-022-04739-3 ↗
44. HTLV-1 viral factor HBZ induces CCR4 to promote T-cell migration and proliferation10.1158/0008-5472.CAN-16-0361 ↗
45. Ovarian cancer stem cells promote tumour immune privilege and invasion via CCL5 and regulatory T cells10.1111/cei.13044 ↗
46. Regulatory T cells with superior immunosuppressive capacity emigrate from the inflamed colon to draining lymph nodes10.1038/mi.2017.64 ↗
47. Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate10.1126/science.1139221 ↗
48. CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice10.1681/ASN.2015020203 ↗
49. Targeting CCR8 induces protective antitumor immunity and enhances vaccine-induced responses in colon cancer10.1158/0008-5472.CAN-18-1119 ↗
50. Regulatory T cells exhibit distinct features in human breast cancer10.1016/j.immuni.2016.10.032 ↗
51. Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells10.1038/nature10169 ↗
52. CXCR5/CXCL13 interaction is important for double-negative regulatory T cell homing to cardiac allografts110.4049/jimmunol.176.9.5276 ↗
53. Gut-tropic T cells that express integrin α4β7 and CCR9 are required for induction of oral immune tolerance in mice10.1053/j.gastro.2011.09.015 ↗
54. Tumors establish resistance to immunotherapy by regulating Treg recruitment via CCR410.1136/jitc-2020-000764 ↗
55. Specific recruitment of CC chemokine receptor 4–positive regulatory T cells in hodgkin lymphoma fosters immune privilege10.1158/0008-5472.CAN-06-0261 ↗
56. Direct priming of antiviral CD8+ T cells in the peripheral interfollicular region of lymph nodes10.1038/ni1557 ↗
57. T cell receptor signaling in the differentiation and plasticity of CD4+ T cells10.1016/j.cytogfr.2022.08.001 ↗
58. Lineage relationship of effector and memory T cells10.1016/j.coi.2013.09.003 ↗
59. Expression of chemokine receptor CXCR3 on T cells affects the balance between effector and memory CD8 T-cell generation10.1073/pnas.1101881108 ↗
60. T cell migration, search strategies and mechanisms10.1038/nri.2015.16 ↗
61. Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer10.1053/j.gastro.2009.10.057 ↗
62. R. Reschke, T.F. Gajewski, CXCL9 and CXCL10 bring the heat to tumors, Science Immunology 7(73) eabq6509.10.1126/sciimmunol.abq6509 ↗
63. CXCR3, a double-edged sword in tumor progression and angiogenesis10.1016/j.bbcan.2013.08.002 ↗
64. Tumor-derived chemokine CCL5 enhances TGF-β–mediated killing of CD8+ T cells in colon cancer by T-regulatory cells10.1158/0008-5472.CAN-11-2493 ↗
65. The spatio-temporal control of effector T cell migration10.1038/s41577-021-00507-0 ↗
66. Reversal of the TCR stop signal by CTLA-410.1126/science.1131078 ↗
67. Restless T cells sniff and go10.1126/science.1133578 ↗
68. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation10.1016/j.immuni.2011.03.018 ↗
69. Antigen transfer and its effect on vaccine-induced immune amplification and tolerance10.7150/thno.75904 ↗
70. J.D. Fisher, W. Zhang, S.C. Balmert, A.M. Aral, A.P. Acharya, Y. Kulahci, J. Li, H.R. Turnquist, A.W. Thomson, M.G. Solari, V.S. Gorantla, S.R. Little, In situ recruitment of regulatory T cells promotes donor-specific tolerance in vascularized composite allotransplantation, Science Advances 6(11) eaax8429.10.1126/sciadv.aax8429 ↗
71. CXCR3 in T cell function10.1016/j.yexcr.2010.12.017 ↗
72. T cell trafficking through lymphatic vessels10.3389/fimmu.2016.00613 ↗
73. T cell migration from inflamed skin to draining lymph nodes requires intralymphatic crawling supported by ICAM-1/LFA-1 interactions10.1016/j.celrep.2016.12.078 ↗
74. A role for LFA-1 in delaying T-lymphocyte egress from lymph nodes10.1038/emboj.2013.33 ↗
75. CD44 binds to macrophage mannose receptor on lymphatic endothelium and supports lymphocyte migration via afferent lymphatics10.1161/CIRCRESAHA.111.300476 ↗
76. A multilayered blood vessel/tumor tissue chip to investigate T cell infiltration into solid tumor tissues10.1039/D1LC00182E ↗
77. Bimolecular complex between rolling and firm adhesion receptors required for cell arrest: CD44 association with VLA-4 in T cell extravasation10.1016/S1074-7613(04)00077-9 ↗
78. Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment10.1038/s41467-023-39817-3 ↗
79. Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors10.1038/s41467-023-40850-5 ↗
80. Integrin α3 promotes TH17 cell polarization and extravasation during autoimmune neuroinflammation10.1126/sciimmunol.adg7597 ↗
81. Transduction of tumor-specific T cells with CXCR2 chemokine receptor improves migration to tumor and antitumor immune responses10.1158/1078-0432.CCR-10-0712 ↗
82. T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model10.1182/blood-2009-03-209650 ↗
83. Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV10.1056/NEJMoa1300662 ↗
84. Islet encapsulation with polyphenol coatings decreases pro-inflammatory chemokine synthesis and T cell trafficking10.1016/j.biomaterials.2017.03.002 ↗
85. Homeostatic regulation of T cell trafficking by a B cell–derived peptide is impaired in autoimmune and chronic inflammatory disease10.1038/nm.3842 ↗
86. Migrating into the tumor: a roadmap for T10.1016/j.trecan.2017.09.006 ↗
87. Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance10.1016/j.immuni.2013.06.014 ↗
88. Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy10.1038/nature15520 ↗
89. EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer10.1038/s43018-021-00185-w ↗
90. Targeting miR-23a in CD8+ cytotoxic T lymphocytes prevents tumor-dependent immunosuppression10.1172/JCI76561 ↗
91. Loss of PTEN promotes resistance to T cell–mediated immunotherapy10.1158/2159-8290.CD-15-0283 ↗
92. Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas10.1172/JCI90644 ↗
93. Melanoma-intrinsic beta-catenin signalling prevents anti-tumour immunity10.1038/nature14404 ↗
94. Reactivation of dysfunctional dendritic cells by a stress-relieving nanosystem resets anti-tumor immune landscape10.1016/j.nantod.2022.101416 ↗
95. Enhanced tumor trafficking of GD2 chimeric antigen receptor T cells by expression of the chemokine receptor CCR2b10.1097/CJI.0b013e3181ee6675 ↗
96. Enhanced expression of CXCR4 facilitates the trafficking of anti-c-Kit chimeric antigen receptor (CAR) T cells to bone marrow and achieves effective donor stem cell engraftment
97. Cooperative immune-mediated mechanisms of the HDAC inhibitor entinostat, an IL15 superagonist, and a cancer vaccine effectively synergize as a novel cancer therapy10.1158/1078-0432.CCR-19-0727 ↗
98. Histone deacetylase 1 controls CD4+ T cell trafficking in autoinflammatory diseases10.1016/j.jaut.2021.102610 ↗
99. Tumor inhibition or tumor promotion? The duplicity of CXCR3 in cancer10.1002/JLB.5MR0320-205R ↗
100. Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy10.1038/ni.3201 ↗